Medicine & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AspenBio Pharma, Inc.
AspenBio Pharma completes $2.2M private placement
June 2nd, 2006
AspenBio Pharma, Inc., (APNB) announced that it has completed and terminated its offering under a private placement of unregistered securities totaling an aggregate of $2,192,000 with $1,428,000 having previously closed on April 13, 2006. A total of 1,565,714 common shares were sold at $1.40 per share in the offering. No warrants were included in the offering and no commissions were paid on the proceeds. The offering was made to accredited investors, including over 95% purchased by two funds that are existing investors in the company as well as an additional investment by the company's president and CEO. The purpose of the private placement is to raise funds for working...
Source: Medicine & Law Weekly (2006-06-02)
|
